News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on AdAlta.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Kick Podcast: Creating hope for debilitating diseases
Investor Guides
Investor Guide: Health & Biotech FY2025 featuring Tim Boreham
Stockhead TV
Long Shortz with AdAlta: New quarter, twice the cash
News
Closing Bell: Local tech talent steps up ahead of blockbuster inflation week
Health & Biotech
AdAlta boosts balance sheet, makes key advances in Q4 FY24
News
Closing Bell: ASX gains as house prices keep climbing; cash is dead as Armaguard falters
Health & Biotech
AdAlta secures $1.9m from exercise of options to advance critical discovery programs
Stockhead TV
Long Shortz with AdAlta: Progressive partnership to spread life-saving immunotherapies
Health & Biotech
AdAlta secures Cell Therapies as cellular immunotherapies manufacturer
News
Closing Bell: Oil weighs on flat ASX; Errawarra jumps 65pc on scent of fresh lithium
Health & Biotech
ASX Health Stocks: Optiscan jumps after signing robotic surgery deal with Mayo Clinic
News
Market Highlights: Novovax doubles; Chalmers calls critical minerals a ‘golden opportunity’
Health & Biotech
AdAlta locks in $3.7m to speed up Phase II clinical trials, near-term partnerships
Stockhead TV
Long Shortz with AdAlta: Strengthening bonds in the fight against cancer
Health & Biotech
AdAlta and SYNthesis BioVentures collaborate on advanced cell-based cancer immunotherapy
Health & Biotech
‘Tide is turning for the healthcare sector’ – ASX biotechs making strong gains in 2024 Part 1
News
